Alexander Sanin

Prof. Alexander Sanin


Research Focus & Metrics

Academic Career Length

49Years (1978-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2013 in Archivum Immunologiae et Therapiae Experimentalis
Verified
Journal Article
Open access
PDF file
APAlexander Vasilyevich Pronin
Alexander Vasilyevich Pronin
LDLeonid L. Danilov
Leonid L. Danilov
ANAlexander N. Narovlyansky
Alexander N. Narovlyansky
ASAlexander Sanin
Alexander Sanin
The ability of plant polyisoprenoids (polyprenols and polyprenyl phosphates) to diminish the levels of serum cholesterol affecting its biosynthetic pathway are highlighted here. Possible mechanism of such process is discussed. It is also noted that polyisoprenoids can prevent toxic injuries of the liver and restore disturbed hepatic functions. The possibility of polyprenyl phosphates to reveal at the same time anti-inflammatory action suppressing lipoxygenase activity and lowering the levels of proinflammatory cytokines will be illustrated. Attention will be focused on the potential usefulness of plant polyisoprenoids in the course of prevention and treatment of hypercholesterolemia. High efficiency for combined use of polyprenyl phosphate and β-sitosterol, which leads to substantial enhancement of the ability to overcome hypercholesterolemia versus the individual constituents will be demonstrated.

1 November 1993 in Journal of General Microbiology
Verified
Journal Article
Closed access
JHJ.-P. Himanen
J.-P. Himanen
LPL. Pyhala
L. Pyhala
ROR.-M. Olander
R.-M. Olander
OMO. Merimskaya
O. Merimskaya
TKT. Kuzina
T. Kuzina
MSM. Sarvas
M. Sarvas
To evaluate the suitability of Bacillus subtilis as a production host of heterologous proteins for pharmaceutical purposes, we assessed the biological activity of this bacterium and its major cell envelope components, lipoteichoic acid (LTA) and peptidoglycan-teichoic acid complex (PG-TA) in several eukaryotic effector assays. LTA and PG-TA were found to be non-toxic for mice and guinea-pigs in a short-term toxicity assay. PG-TA was weakly pyrogenic and weakly mitogenic. Both LTA and PG-TA acted as immunologic adjuvants in mice and when injected in mice, also caused an increase in the number of granulocyte-monocyte colony-forming cells in the bone marrow probably via stimulation of production of granulocyte-macrophage colony-stimulating factor.

31 October 2024 in Viruses
Verified
Journal Article
Open access
PDF file
ANAlexander N. Narovlyansky
Alexander N. Narovlyansky
APAlexander Vasilyevich Pronin
Alexander Vasilyevich Pronin
VPVladislav Poloskov
Vladislav Poloskov
ASAlexander Sanin
Alexander Sanin
MMMarina Vladimirovna Mezentseva
Marina Vladimirovna Mezentseva
EBEgor Bogdanov
Egor Bogdanov
Ongoing outbreaks and often rapid spread of infections caused by coronaviruses, influenza, Nipah, Dengue, Marburg, monkeypox, and other viruses are a concern for health authorities in most countries. Therefore, the search for and study of new antiviral compounds are in great demand today. Since almost all viruses with pandemic potential have immunotoxic properties of various origins, particular attention is paid to the search and development of immunomodulatory drugs. We have synthesised a new compound related to indole-3-carboxylic acid derivatives (hereinafter referred to as the XXV) that has antiviral and interferon-inducing activity. The purpose of this work is to study the effect of the XXV on the stimulation of the expression of toll-like receptor genes, interferons, and immunoregulatory cytokines in a macrophage-like cell model. In this study, real-time PCR methods were used to obtain data on the transcriptional activity of genes in macrophage-like cells. Stimulation of the genes of toll-like receptors TLR2, TLR3, TLR4, TLR7, TLR8, and TLR9 was detected. A high-fold increase in stimulation (from 6.5 to 16,000) of the expression of the TLR3 and TLR4 genes was detected after 4 h of exposure to the XXV. Increased activity of interferon (IFNA1, IFNA2, IFNB1, IFNK, and IFNλ1) genes with simultaneous stimulation of the expression of interferon receptor (IFNAR1 and IFNAR2) genes and signalling molecule (JAK1 and ISG15) genes was detected. Increased fold stimulation of the expression of the cytokine genes IL6, TNFA, IL12A, and IL12B was also observed. Thus, it is shown that the XXV is an activator of TLR genes of innate immunity, which trigger signalling mechanisms of pathogen “recognition” and lead to stimulation of the expression of genes of proinflammatory cytokines and interferons.

1 August 2016 in Cytokine & Growth Factor Reviews
Verified
Journal Article
Closed access
APAlexander Vasilyevich Pronin
Alexander Vasilyevich Pronin
ANAlexander N. Narovlyansky
Alexander N. Narovlyansky
ASAndrey E. Shulzhenko
Andrey E. Shulzhenko
ASAlexander Sanin
Alexander Sanin
ASAlexander M. Sedov
Alexander M. Sedov

18 December 2023 in Acta Naturae
Verified
Journal Article
Open access
PDF file
ANAlexander N. Narovlyansky
Alexander N. Narovlyansky
MFMarina Filimonova
Marina Filimonova
NTN. G. Tsyshkova
N. G. Tsyshkova
APAlexander Vasilyevich Pronin
Alexander Vasilyevich Pronin
Tatiana Vladimirovna GrebennikovaTatiana Vladimirovna Grebennikova
Tatiana Vladimirovna Grebennikova
AGA. L. Gintsburg
A. L. Gintsburg
The coronavirus disease (COVID-19) pandemic has brought into sharp relief the threat posed by coronaviruses and laid the foundation for a fundamental analysis of this viral family, as well as a search for effective anti-COVID drugs. Work is underway to update existent vaccines against COVID-19, and screening for low-molecular-weight anti-COVID drug candidates for outpatient medicine continues. The opportunities and ways to accelerate the development of antiviral drugs against other pathogens are being discussed in the context of preparing for the next pandemic. In 2012–2015, Tsyshkova et al. synthesized a group of water-soluble low-molecular-weight compounds exhibiting an antiviral activity, whose chemical structure was similar to that of arbidol. Among those, there were a number of water-soluble compounds based on 5-methoxyindole-3-carboxylic acid aminoalkyl esters. Only one member of this rather extensive group of compounds, dihydrochloride of 6-bromo-5-methoxy-1-methyl-2-(1-piperidinomethyl)-3-(2-diethylaminoethoxy)carbonylindole, exhibited a reliable antiviral effect against SARS-CoV-2 in vitro. At a concentration of 52.0 μM, this compound completely inhibited the replication of the SARS-CoV-2 virus with an infectious activity of 106 TCID50/mL. The concentration curves of the analyzed compound indicate the specificity of its action. Interferon-inducing activity, as well as suppression of syncytium formation induced by the spike protein (S-glycoprotein) of SARS-CoV-2 by 89%, were also revealed. In view of its synthetic accessibility − high activity (IC50 = 1.06 µg/mL) and high selectivity index (SI = 78.6) − this compound appears to meets the requirements for the development of antiviral drugs for COVID-19 prevention and treatment.

1 July 2002
Verified
Journal Article
Closed access
APAlexander V Pronin
Alexander V Pronin
EGEkaterina A Grigorieva
Ekaterina A Grigorieva
ASAlexander Sanin
Alexander Sanin
ANAlexander N. Narovlyansky
Alexander N. Narovlyansky
SOSergei V Ozherelkov
Sergei V Ozherelkov
ANAbderrahim Najid
Abderrahim Najid